Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.

Authors :: Sniderman AD
Furberg CD
Keech A
Roeters van Lennep JE
Frohlich J
Jungner I
Walldius G
Source :: Lancet (London, England) [Lancet] 2003 Mar 01; Vol. 361 (9359), pp. 777-80.
Publication Year :: 2003

Subjects :: Cholesterol, LDL blood
Coronary Artery Disease blood
Humans
Risk Factors
Anticholesteremic Agents therapeutic use
Apolipoproteins B blood
Cholesterol blood
Coronary Artery Disease drug therapy
Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use

Full Text Access

Tools